Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Arterial spin labeling (ASL) is a non-invasive MRI technique that could help the radiologists to distinguish brain metastasis progression versus radionecrosis following gamma-knife treatment.
The primary target of the study is to establish the diagnostic performances (specificity, sensitivity) of quantitative measures of ASL in brain metastases suspected of progression/radionecrosis after GK treatment
The metastasis progression versus radionecrosis following GK treatment can sometimes be difficult to distinguish. 60 patients will be included in this prospective, monocentric study. 3 MRI (baseline, 1month and 6 month follow-ups) will be performed. Two neuroradiologists will blindly analyse the MRIs comparing ASL sensibility and specificity to the standard morphological evaluation and T2 perfusion.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adults with brain metastases treated with Gamma Knife whose lesions suggest tumor recurrence versus | Experimental | Inclusion visit, 1 month later, 6 month later |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MRI perfusion sequence | Other | Quantitative analysis |
|
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic performance of ASL quantitative analysis in brain metastasis following GK treatment : tumor perfusion with quantitative measurement (one value) of RCBF (relative cerebral blood flow) on the ASL sequence | Quantitative analysis (rCBF) of the evolution of brain metastasis between the initiation of treatment and 6 months after. | Evolution between Baseline MRI, 1 and 6 month follow up MRI |
| Measure | Description | Time Frame |
|---|---|---|
| ASL Perfusion: Cerebral blood flow measurements | Baseline MRI, 1 and 6 month follow up MRI | |
| Interreader correlation | Two neuroradiologists | Baseline MRI, 1 and 6 month follow-up MRI |
Not provided
Inclusion Criteria:
Brain metastasis from histologically proven tumor
GK treatment within 4 month prior to the inclusion
Lesions suspected of progression/ radionecrosis :
i.e.≥ 25% of the size progression
Lesion size: gadolinium enhanced part of the tumour ≥1 cm
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Natalia SHOR, MD | Contact | +330661884335 | shor.natalia@icloud.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Service de neuroradiologie, hôpital Pitié Salpêtrière | Recruiting | Paris | 75013 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001932 | Brain Neoplasms |
| D009362 | Neoplasm Metastasis |
| ID | Term |
|---|---|
| D016543 | Central Nervous System Neoplasms |
| D009423 | Nervous System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Morphological analysis of the lesions | Lesion size, oedema | Baseline MRI, 1 and 6 month follow-up MRI |
| D001927 |
| Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D009385 | Neoplastic Processes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |